SAFETY AND EFFICACY OF BENDAMUSTINE WITH OR WITHOUT RITUXIMAB IN THE TREATMENT OF HEAVILY PRETREATED PATIENTS WITH LYMPHOMA OR CLL. A MULTICENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Rigacci, L. [1 ]
Puccini, B. [1 ]
D'Arco, A. [2 ]
Orciuolo, E. [3 ]
Cortelazzo, S. [4 ]
Gaidano, G. [5 ]
Patti, C. [6 ]
Musto, P. [7 ]
Zinzani, P. L. [8 ]
Storti, S. [9 ]
Carpaneto, A. [10 ]
Di Renzo, N. [11 ]
Cascavilla, N. [12 ]
Petrizzi, V. Belsito [2 ]
Cecconi, N. [3 ]
Buda, G. [3 ]
Franceschetti, S. [5 ]
Derenzini, E.
Costa, A. [6 ]
Giordano, G. [9 ]
Montanaro, M. [10 ]
Billio, A. [4 ]
Mansueto, G. [7 ]
Bosi, A. [1 ]
机构：
[1] Azienda Osped Careggi, Florence, Italy
[2] Ematooncol Nocera Inferiore, Nocera Inferiore, Italy
[3] Dept Oncol Transplans & Adv, Pisa, Italy
[4] Ematol Osped Reg Bolzano, Bolzano, Italy
[5] Dpt Clin & Expt Med, Div Hematol, Novara, Italy
[6] Ematol Osped Cervello, Palermo, Italy
[7] Ctr Riferimento Oncol Basilicata, IRCCS, Rionero In Vulture, Italy
[8] Ematol Osped L&A Seragnoli, Bologna, Italy
[9] Univ Cattolica Sacro Cuore, UOC Oncoematol, Campobasso, Italy
[10] Ematol Osped Roncigl, Viterbo, Italy
[11] Ematol Osped V Fazzi, Lecce, Italy
[12] Ematol Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0431
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [21] Rituximab (Mabthera™, Rituxan™) in patients with recurrent indolent lymphoma -: Evaluation of safety and efficacy in a multicenter study
    Walewski, J
    Kraszewska, E
    Mioduszewska, O
    Romejko-Jarosinska, J
    Hellmann, A
    Czyz, J
    Holowiecki, J
    Kopera, M
    Grosicki, S
    Komarnicki, M
    Rumianowski, L
    Kuliczkowski, K
    Wróbel, T
    Dwilewicz-Trojaczek, J
    Robak, T
    Warzocha, K
    Zaluski, J
    Wójcik, E
    Dmoszynska, A
    Walter-Croneck, A
    MEDICAL ONCOLOGY, 2001, 18 (02) : 141 - 148
  • [22] Efficacy and Safety Of Bendamustine In Combination With Rituximab For Elderly Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia. A Retrospective Multicenter Study
    Laurenti, Luca
    Vannata, Barbara
    Innocenti, Idanna
    Autore, Francesco
    Ghio, Francesco
    Cecconi, Nadia
    Pitini, Vincenzo
    Mondello, Patrizia
    Lanza Cariccio, Maria Rosa
    Gozzetti, Alessandro
    D'Arena, Giovanni
    Murru, Roberta
    Piccirillo, Nicola
    Leone, Giuseppe
    Sica, Simona
    BLOOD, 2013, 122 (21)
  • [23] Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
    Iannitto, Emilio
    Morabito, Fortunato
    Mancuso, Salvatrice
    Gentile, Massimo
    Montanini, Antonella
    Augello, Accursio
    Bongarzoni, Velia
    D'Arco, Alfonso
    Di Renzo, Nicola
    Fazzi, Rita
    Franco, Giovanni
    Marasca, Roberto
    Mule, Antonino
    Musso, Maurizio
    Musto, Pellegrino
    Pennese, Elsa
    Piccin, Andrea
    Rota-Scalabrini, Delia
    Visani, Giuseppe
    Rigacci, Luigi
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (03) : 351 - 357
  • [24] Real-World Efficacy and Safety of Bendamustine with or without Rituximab in Treatment-Naive Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of a German Registry
    Guenther, Georg
    Bartels, Stefan
    Tessen, Hans-Werner
    Sterchele, James A.
    BLOOD, 2012, 120 (21)
  • [25] Efficacy and safety of bendamustine and rituximab in the treatment of indolent and mantle cell lymphomas in older patients
    Rummel, M. J.
    Heine, K.
    Bodenstein, H.
    Baldus, M.
    Stauch, M.
    von Gruenhagen, U.
    Banat, A.
    Kaiser, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Safety and Efficacy of Bendamustine-Rituximab in Treatment Naïve Symptomatic Follicular Lymphoma: An Institutional Analysis
    Ajay Gogia
    Sudhir Kumar
    Lalit Kumar
    Atul Sharma
    Soumya Mallick
    Indian Journal of Hematology and Blood Transfusion, 2021, 37 : 169 - 170
  • [27] Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer
    Bouchahda, M.
    Macarulla, T.
    Spano, J. P.
    Bachet, J. B.
    Lledo, G.
    Andre, T.
    Landi, B.
    Tabernero, J.
    Karaboue, A.
    Domont, J.
    Levi, F.
    Rougier, P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 67 (03) : 255 - 262
  • [28] EFFICACY AND SAFETY OF BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS FIRST-LINE TREATMENT FOR PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA OR MANTLE CELL LYMPHOMA
    Cencini, E.
    Fabbri, A.
    Iannuzzi, A.
    Schiattone, L.
    Brambilla, C. Zuanelli
    Bocchia, M.
    HAEMATOLOGICA, 2017, 102 : 112 - 112
  • [29] RITUXIMAB-BENDAMUSTINE IN THE TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A RETROSPECTIVE STUDY OF THE GELCAB GROUP
    Quintela, D.
    Garcia, O.
    Lopez, Pereira P.
    Mozas, P.
    Muntanola, A.
    Mercadal, S.
    Lopez-Guillermo, A.
    De la Fuente, C.
    Huguet, M.
    Franch, M.
    Sorigue, M.
    Moreno, M.
    Sancho, J. M.
    HAEMATOLOGICA, 2021, 106 (10) : 295 - 295
  • [30] EFFICACY AND SAFETY OF BENDAMUSTINE IN COMBINATION WITH RITUXIMAB FOR ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA. AN ITALIAN RETROSPECTIVE MULTICENTER STUDY
    Laurenti, L.
    Autore, F.
    Innocenti, I.
    Vannata, B.
    Cantonetti, M.
    Del Principe, M. I.
    Mauro, F. R.
    Borza, P. Anticoli
    Bongarzoni, V.
    Ciolli, S.
    Boncompagni, R.
    Sciume, M.
    Vincenti, D.
    Ghio, F.
    Cecconi, N.
    Pitini, V.
    Mondello, P.
    Cariccio, M. R. Lanza
    Gozzetti, A.
    D'Arena, G.
    Murru, R.
    Piccirillo, N.
    Petrini, M.
    Cortelezzi, A.
    Del Poeta, G.
    Foa, R.
    Sica, S.
    HAEMATOLOGICA, 2014, 99 : 324 - 325
12345